Search

1. Insulin degludec (Tresiba??, Novo Nordisk A/S) for the treatment of diabetes: effectiveness, value, and value-based price benchmarks : final report

Author(s):

Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Chapman, Rick, author
Shore, Karen K., author
Weissberg, Jed, author
Pearson, Steven D., author

Publication:

[Boston, MA] : Institute for Clinical and Economic Review, March 14, 2016

Subject(s):

Blood Glucose -- drug effects
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 2 -- drug therapy
Hypoglycemia -- prevention & control
Hypoglycemic Agents -- therapeutic use
Insulin, Long-Acting -- administration & dosage
Insulin, Long-Acting -- therapeutic use
Blood Glucose -- metabolism
Cost-Benefit Analysis
Diabetes Mellitus, Type 1 -- blood
Diabetes Mellitus, Type 1 -- complications
Diabetes Mellitus, Type 2 -- blood
Diabetes Mellitus, Type 2 -- complications
Hypoglycemia -- blood
Hypoglycemia -- chemically induced
Hypoglycemic Agents -- administration & dosage
Insulin -- adverse effects
Severity of Illness Index
Humans
United States

2. Treating hyperkalemia: avoid additional harm when using insulin and dextrose

Author(s):

Lawes, Staley, author
Gaunt, Michael J., author
Grissinger, Matthew, author

Publication:

[Harrisburg, Pa.] : Pennsylvania Patient Safety Authority, September 2017

Subject(s):

Hyperkalemia -- drug therapy
Hypoglycemia -- chemically induced
Hypoglycemia -- prevention & control
Medication Errors -- prevention & control
Glucose -- administration & dosage
Glucose -- adverse effects
Hypoglycemia -- drug therapy
Insulin -- administration & dosage
Insulin -- adverse effects
Patient safety
Humans
Pennsylvania
United States